Claude Leclerc

Part of Thermo Fisher Scientific, Inc., Life Technologies BPD UK Ltd. supplies cell culture and bioprocessing systems. The company is based in Altrincham, UK.

Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Bruker Daltonics Ltd. manufactures mass spectrometry instruments and accessories for life science, pharmaceutical, biochemical, and chemical research as well as for more routine analytical tasks in forensics and food safety. It also provides nuclear, biological, and chemical detection services, with a CBRNE product line based on a broad array of technologies, including mass and ion mobility spectrometry. The company is headquartered in Coventry, UK.

Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France.

Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France.

American Hospital of Paris provides healthcare services. It offers medical, surgical and obstetrical, check-ups, maternity, thyroid and vascular surgery services. The company was founded in 1906 and is headquartered in Neuilly-sur-Seine, France.

ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France.

Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France.

InGen Biosciences SA is engaged in the development of in-vitro diagnostic products for use in medical biology laboratories. The company was founded in 1993 and it is headquartered in Chilly-Mazarin, France.

Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France.

Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.

Institut Curie engages as a non-profit foundation. It operates a research center on biophysics, cell biology, and oncology and a hospital specialized in treatment of cancer. The company was founded in 1909 and is headquartered in Paris, France.

Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.

Bio-Rad Innovations SAS engages in the development and production of chemicals used in biochemical, pharmaceutical and other life science research applications. The company is headquartered in Paris, France.

Bio Intelligence Service SAS provides health information and environmental consultancy services. It specializes in research and consultancy in the field of environmental and health information on products. The company was founded by Eric Labouze and Pierre Sonigo in 1989 and is headquartered in Paris, France.

France Recherche Nord & Sud SIDA HIV- Hepatites engages in research on HIV and viral hepatitis. The company was founded on 1988 and is headquartered in Paris, France.

Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China.

The Institute of Science & Technology Austria (ISTA) is a research institute that provides scientific service units to avoid duplication of efforts and expenses. The private company is based in Klosterneuburg, Austria, and has subsidiaries in Austria. The Austrian company also offers family services to support employees with family questions and continuously provide services to balance work and family life. ISTA provides full-time postdoctoral positions to highly qualified candidates who have recently completed their PhD or equivalent in natural or computer sciences, mathematics, or any related discipline. The Communications & Events department of ISTA has developed different formats to communicate science to diverse target groups. ISTA provides a world-class environment for science and is committed to the highest international academic standards.

PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France.

Pradeyrol Développement SC operates as an investment holding company. It invests in the biotechnology sector and mainly on molecular diagnostics. The company was founded on August 16, 2007 and is headquartered in Paris, France.

Medicen Paris Region is a health competitiveness cluster based in the Île-de-France region. The French company aims to promote local industrialization and respond to health sovereignty challenges. The non-profit company offers various job opportunities that can be found on their website.

Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo.

Marochar SAS is a French company that specializes in the retail sale of hardware, paints, and glass. The private company is based in Les Sables d'Olonne, France. The company was founded in 1999, and Christine Petit has been the CEO of the company since 2011.

Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward.